Skip to content

The early intervention of fascia iliaca compartment block (FICB) as pain management for elderly patients with hip fracture to improve postoperative rehabilitation: A prospective randomized controlled study

The early intervention of fascia iliaca compartment block (FICB) as pain management for elderly patients with hip fracture to improve postoperative rehabilitation: A prospective randomized controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600126825
Enrollment
Unknown
Registered
2026-06-16
Start date
2026-07-01
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hip fracture

Interventions

early intervention group:early intervention of fascia iliaca compartment block (FICB) as pain management for elderly patients with hip fracture
non-early intervention group:non-early intervention of fascia iliaca compartment block (FICB) as pain management for elderly patients with hip fracture

Sponsors

Renji Hospital affiliated to Shanghai Jiaotong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age >=65 years old; 2. Diagnosed as hip fracture, such as a unilateral femoral neck fracture or an intertrochanteric (intro-trochanteric) fracture via imaging (X-ray, CT or MRI); 3. Planned hip surgery under general anaesthesia with endotracheal intubation due to a hip fracture (total hip replacement, partial hip replacement, intertrochanteric intramedullary nailing, closed reduction and internal fixation, etc.); 4. ASA I–III; 5. Informed consent from the patient or their legal representative; 6. Able to communicate fluently in Chinese.

Exclusion criteria

Exclusion criteria: 1. Allergy to ropivacaine or bupivacaine/liposomes; 2. Contraindications to nerve block (nerve damage, coagulation disorders, severe infection or exudate at the puncture site, etc.); 3. A history of psychiatric or neurological disorders such as depression, severe central nervous system depression, Parkinson’s disease, basal ganglia disorders, schizophrenia, epilepsy, Alzheimer’s disease or myasthenia gravis; 4. A history of severe abnormalities in cardiac, pulmonary, hepatic or renal function, such as heart failure or the need for dialysis; 5. Unable to communicate before the surgery (due to coma or dementia); 6. Preoperative pain score (VAS score) < 4 or old hip fracture; 7. Participants currently enrolled in other clinical trials; 8. Researchers consider that participants are unsuitable for this trial if they are unable to assess treatment efficacy or are unlikely to complete the intended course of treatment and follow-up.

Design outcomes

Primary

MeasureTime frame
QoR-15 score;

Secondary

MeasureTime frame
Sleep duration and quality score;NRS score;Length of hospital stay and overall satisfaction score for pain management;Incidence of delirium;Total use of opioids and other analgesics during the perioperative period;Time of extubation during the recovery phase; incidence of agitation during the recovery phase;

Countries

China

Contacts

Public ContactZhao Yanhua

Renji Hospital affiliated to Shanghai Jiaotong University School of Medicine

18017464717@qq.com+86 21 58752345

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 29, 2026